Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 226 | 263 | $40,240 | $13,594 |
| 2022 | 13 | 1,779 | 2,091 | $351,560 | $131,285 |
| 2021 | 8 | 498 | 521 | $85,021 | $40,741 |
| 2020 | 10 | 371 | 403 | $59,685 | $31,891 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 63 | 63 | $19,909 | $5,771 | 29.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 40 | 44 | $7,001 | $3,186 | 45.5% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 41 | 42 | $3,570 | $1,454 | 40.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 30 | 62 | $4,770 | $1,006 | 21.1% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 18 | 18 | $2,475 | $905.04 | 36.6% |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | Office | 2023 | 11 | 11 | $1,350 | $808.50 | 59.9% |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | Office | 2023 | 11 | 11 | $520.00 | $269.50 | 51.8% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 12 | 12 | $645.00 | $194.40 | 30.1% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 555 | 555 | $167,992 | $58,782 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 242 | 324 | $54,690 | $28,012 | 51.2% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 409 | 467 | $42,849 | $16,276 | 38.0% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2022 | 231 | 251 | $36,070 | $12,736 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 52 | 52 | $20,172 | $7,133 | 35.4% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 111 | 221 | $14,170 | $3,585 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 21 | 21 | $6,076 | $2,056 | 33.8% |
| 87400 | Detection test by immunoassay technique for influenza virus | Office | 2022 | 37 | 73 | $3,650 | $1,012 | 27.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 55 | 56 | $3,135 | $908.98 | 29.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 14 | 14 | $1,354 | $625.71 | 46.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 26 | 29 | $810.00 | $64.18 | 7.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 14 | $252.00 | $48.00 | 19.0% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 12 | 14 | $340.00 | $45.08 | 13.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 174 | 174 | $39,302 | $19,731 | 50.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 78 | 84 | $11,862 | $7,234 | 61.0% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 130 | 137 | $11,870 | $4,840 | 40.8% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 60 | 68 | $10,515 | $3,489 | 33.2% |
About Dr. Ruchir Thakkar, D.O
Dr. Ruchir Thakkar, D.O is a Family Medicine healthcare provider based in Cicero, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/01/2011. The National Provider Identifier (NPI) number assigned to this provider is 1174812853.
As a Medicare-enrolled provider, Thakkar has provided services to 2,874 Medicare beneficiaries, totaling 3,278 services with total Medicare billing of $217,510. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Cicero, IL
- Active Since 04/01/2011
- Last Updated 04/05/2017
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1174812853
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Cicero
Daniel Rancier, Md, MD
Family Medicine — Payments: $12,897
Amado Rueda, Md, MD
Family Medicine — Payments: $11,222
Hernan Reyes, Md, MD
Family Medicine — Payments: $10,362
Rosaura Licea, Md, MD
Family Medicine — Payments: $8,416
Hemlata Meena, M.d, M.D
Family Medicine — Payments: $8,405
Dennis Nave, Md, MD
Family Medicine — Payments: $6,961